Epirubicin directly promotes hepatitis B virus (HBV) replication in stable HBV-expressing cell lines: A novel mechanism of HBV reactivation following anticancer chemotherapy

Molecular Medicine Reports

Volumn 9, Issue 4, 2014, Pages 1345-1350

  Xu, Lei ^a   Tu, Zeng ^a   Xu, Ge ^a   Wang, Yuwei ^a   Pan, Wanlong ^b   Zhan, Xingxing ^a   Luo, Qiang ^a   Huang, Yuan ^a   Chen, Juan ^a   Huang, Ailong ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

Author keywords

Chemotherapy; Epirubicin; Hepatitis B virus; Mechanism; Reactivation

Indexed keywords

EPIRUBICIN; HEPATITIS B CORE ANTIGEN; VIRUS DNA; VIRUS RNA;

ACUTE LIVER FAILURE; ARTICLE; CANCER CHEMOTHERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B VIRUS; HYPOTHESIS; IN VITRO STUDY; MTT ASSAY; SOUTHERN BLOTTING; UPREGULATION; VIRUS NUCLEOCAPSID; VIRUS REACTIVATION; VIRUS REPLICATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; DNA, VIRAL; DRUG THERAPY; EPIRUBICIN; HEPATITIS B VIRUS; HUMANS; NUCLEOCAPSID; RNA, VIRAL; UP-REGULATION; VIRION; VIRUS ACTIVATION; VIRUS REPLICATION;

EID: 84896513596     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.1973     Document Type: Article

References (22)

1. Liu CJ, Chen PJ, Chen DS and Kao JH: Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management. Hepatol Int 7: 316-326, 2013.
2. Lubel JS and Angus PW: Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: diagnosis and management. J Gastroenterol Hepatol 25: 864-871, 2010.
3. Tur-Kaspa R, Burk RD, Shaul Y and Shafritz DA: Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci USA 83: 1627-1631, 1986. (Pubitemid 16018617)
4. Liaw YF: Hepatitis viruses under immunosuppressive agents. J Gastroenterol Hepatol 13: 14-20, 1998.
5. Cheng AL, Hsiung CA, Su IJ, Chen PJ, Chang MC, Tsao CJ, Kao WY, Uen WC, Hsu CH, Tien HF, et al; Lymphoma Committee of Taiwan Cooperative Oncology Group: Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma. Hepatology 37: 1320-1328, 2003. (Pubitemid 36667311)
6. Hwang JP, Vierling JM, Zelenetz AD, Lackey SC and Loomba R: Hepatitis B virus management to prevent reactivation after chemotherapy: a review. Support Care Cancer 20: 2999-3008, 2012.
7. Nassal M: The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J Virol 66: 4107-4116, 1992.
8. Muscarella DE and Bloom SE: The contribution of c-Jun N-terminal kinase activation and subsequent Bcl-2 phosphorylation to apoptosis induction in human B-cells is dependent on the mode of action of specific stresses. Toxicol Appl Pharmacol 228: 93-104, 2008.
9. Zhu X, Fu A and Luo KQ: A high-throughput fluorescence resonance energy transfer (FRET)-based endothelial cell apoptosis assay and its application for screening vascular disrupting agents. Biochem Biophys Res Commun 418: 641-646, 2012.
10. Sells MA, Chen ML and Acs G: Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA 84: 1005-1009, 1987. (Pubitemid 17031557)
11. Zhang Z, Liu X, Chen J, Su H, Luo Q, Ye J, Tang N, Zhang W, Chen W, Ko BC and Huang A: Heparin sulphate D-glucosaminyl 3-O-sulfotransferase 3B1 plays a role in HBV replication. Virology 406: 280-285, 2010.
12. Manzano-Alonso ML and Castellano-Tortajada G: Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy. World J Gastroenterol 17: 1531-1537, 2011.
13. Dai MS, Wu PF, Shyu RY, Lu JJ and Chao TY: Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration. Liver Int 24: 540-546, 2004. (Pubitemid 40028604)
14. Yeo W, Zee B, Zhong S, Chan PK, Wong WL, Ho WM, Lam KC and Johnson PJ: Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy. Br J Cancer 90: 1306-1311, 2004. (Pubitemid 38586252)
15. Yeo W, Chan PK, Zhong S, Ho WM, Steinberg JL, Tam JS, Hui P, Leung NW, Zee B and Johnson PJ: Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. J Med Virol 62: 299-307, 2000.
16. Lau JY, Bain VG, Smith HM, Alexander GJ and Williams R: Modulation of hepatitis B viral antigen expression by immunosuppressive drugs in primary hepatocyte culture. Transplantation 53: 894-898, 1992.
17. McMillan JS, Shaw T, Angus PW and Locarnini SA: Effect of immunosuppressive and antiviral agents on hepatitis B virus replication in vitro. Hepatology 22: 36-43, 1995.
18. Farci P, Diaz G, Chen Z, Govindarajan S, Tice A, Agulto L, Pittaluga S, Boon D, Yu C, Engle RE, et al: B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure. Proc Natl Acad Sci USA 107: 8766-8771, 2010.
19. Wu W, Chen Z, Cheng N, Watts NR, Stahl SJ, Farci P, Purcell RH, Wingfield PT and Steven AC: Specificity of an anti-capsid antibody associated with Hepatitis B Virus-related acute liver failure. J Struct Biol 181: 53-60, 2013.
20. Casavant NC, Luo MH, Rosenke K, Winegardner T, Zurawska A and Fortunato EA: Potential role for p53 in the permissive life cycle of human cytomegalovirus. J Virol 80: 8390-8401, 2006. (Pubitemid 44384852)
21. Huang YQ, Wang LW, Yan SN and Gong ZJ: Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells. Hepatobiliary Pancreat Dis Int 3: 543-547, 2004.
22. Wang S, Qiu L, Yan X, Jin W, Wang Y, Chen L, Wu E, Ye X, Gao GF, Wang F, et al: Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1)-modulated P53 activity. Hepatology 55: 730-741, 2012.